La ricerca è una priorità per SIFaCT e la pubblicazione del paper su una rivista scientifica di livello internazionale è il risultato finale e tangibile del lavoro svolto. Di seguito le pubblicazioni vengono suddivise secondo diversi criteri per facilitare la selezione dell’articolo di interesse prodotto dalla società scientifica.

Nel riquadro a destra puoi selezionare i seguenti 4 filtri: Anno di pubblicazione – Primo autore – Impact factor – Topic

Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data

Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparison

Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials

Effectiveness of Patent Foramen Ovale Occlusion Devices Versus Medical Therapy: An Indirect Comparison Based on Reconstructed Individual Patient Data

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (” PEMBROREAL” Study)

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens